Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism worsens quality of life and mental health, and treatment with both medical help and therapy is most effective.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Hair analysis shows low progesterone in anorexia patients, unchanged by short-term weight gain.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

The removal of the adrenal tumor improved the patient's symptoms and reduced androgen levels, indicating successful surgery.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Women with PCOS have higher levels of certain hormones compared to healthy women, and these levels vary with BMI, age, and treatment type.

Diane-35 effectively reduces hair loss and thinning in women.

Lifestyle changes like a healthy diet, exercise, and proper sleep can help manage PCOD.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

Most women with hirsutism have normal hormone levels and can be treated with cosmetic methods; obesity and PCOS are common causes, and treatments depend on the underlying issue.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Future treatments for hair loss may focus on personalized and regenerative approaches.